AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome.

by Jitka Koblihova, Klara Srutova, Monika Krutska, Hana Klamova, Katerina Machova Polakova
Published 2018-01-01

Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment

by Zuzana Humlová, Hana Klamová, Ivana Janatková, Karin Malícková, Petra Králíková, Ivan Šterzl, Zdeněk Roth, Eva Hamšíková, Vladimír Vonka
Published 2010-01-01

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

by Monika Jaruskova, Nikola Curik, Rajna Hercog, Vaclava Polivkova, Eliska Motlova, Vladimir Benes, Hana Klamova, Pavla Pecherkova, Petra Belohlavkova, Filip Vrbacky, Katerina Machova Polakova
Published 2017-04-01

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in Hi...

by Vaclava Polivkova, Peter Rohon, Hana Klamova, Olga Cerna, Martina Divoka, Nikola Curik, Jan Zach, Martin Novak, Iuri Marinov, Simona Soverini, Edgar Faber, Katerina Machova Polakova
Published 2016-01-01

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining

by Nikola Curik, Nikola Curik, Vaclava Polivkova, Pavel Burda, Pavel Burda, Jitka Koblihova, Adam Laznicka, Adam Laznicka, Tomas Kalina, Veronika Kanderova, Jana Brezinova, Sarka Ransdorfova, Dominika Karasova, Katerina Rejlova, Marina Bakardjieva, Daniela Kuzilkova, David Kundrat, Jana Linhartova, Hana Klamova, Cyril Salek, Pavel Klener, Pavel Klener, Ondrej Hrusak, Katerina Machova Polakova, Katerina Machova Polakova
Published 2021-09-01